[Dihydroergocristine methanesulfonate: treatment of a severe case of perypheral ischemia induced by ergotamine tartrate].
D004088:Dihydroergotoxine / Q000627:therapeutic use*; D004879:Ergotamines / Q000009:adverse effects*; D005121:Extremities / Q000098:blood supply; D006801:Humans; D007511:Ischemia / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D008698:Mesylates / Q000627:therapeutic use; D008875:Middle Aged; D013644:Tartrates / Q000009:adverse effects; D014653:Vascular Headaches / Q000188:drug therapy
D004879:Ergotamines; D008698:Mesylates; D013644:Tartrates; D004088:Dihydroergotoxine
Dihidroergocristina metansulfonato: tratamiento de un grave caso de isquemia periférica inducida por tartrato de ergotamina.